NEW YORK, June 1, 2015 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Amedisys, Inc. shareholders (NASDAQ:AMED). Concerned AMED investors who purchased between February 28, 2012 and May 28, 2015 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

The law firm is investigating Amedisys, Inc. for possible violations of the federal securities laws. After the close of trading on May 28, 2015, Amedisys announced that it had received a Subpoena Duces Tecum from the U. S. Department of Justice on May 21, 2015. The Subpoena requests that information be delivered to them regarding 53 identified hospice patients to the United States Attorney's Office for the District of Massachusetts.  The Subpoena also requests that documents be delivered to Amedisys' hospice clinical and business operations and related compliance activities. Amedisys is fully cooperating with the U. S. Department of Justice with respect to this investigation.  There are no assurances as to the timing or outcome of the investigation. On this news, shares of Amedisys are falling as much as $1.75 or almost 5.5% to as low as 30.08 on intraday trading on May 29, 2015.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. AMED stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@dunnamlaw.com with questions, toll free at (844) 702-2990 or visit http://www.dunnamlaw.com/AMED.

Find these Waco business attorneys on social media on Google+, LinkedIn, Facebook, and Twitter.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/amedisys-inc-investors-encouraged-to-contact-securities-law-firm-about-investigation-into-allegations-of-corporate-wrongdoing-300091700.html

SOURCE Dunnam & Dunnam